The Medi-Cal Rx Monthly Bulletin for December has been posted. Below is an outline of this month’s updates. As a reminder, Medi-Cal Rx is schedule to be implemented effective January 1, 2021.
- Changes to the Contract Drugs List (CDL), Effective December 1, 2021
- Changes to the Contract Drugs List (CDL) – Over the Counter Drugs, Effective December 1, 2021
- Changes to the Family PACT Pharmacy Formulary, Effective December 1, 2021
- Medi-Cal Rx Medical Supplies Updates
- Reimbursement for COVID-19 Vaccine Administration Claims
- Updates to the Medi-Cal Rx Provider Manual
- Adult Vaccination Administration Fee: Pharmacy Claims and Reimbursement
- Maximum Allowable Ingredient Cost (MAIC) 30-Day Pharmacy Provider Notice
- 45-Day Pharmacy Provider Notice
- Contract Drugs List (CDL) Flyer
- Medi-Cal Rx Provider Training Details
- Registering Multiple NPIs in UAC
- UAC Registration and Sign-In Troubleshooting
- UAC Registration Reminders and Helpful Tips
- Introducing the Medi-Cal Rx Education and Outreach Team
- Prescriber Training Checklist
- Pharmacy Training Checklist
Also in California, NACDS submitted comments to the Board of Pharmacy in support of the proposed rule revising 16 CCR §1746.4 pertaining to requirements for notification to patients’ primary care provider following vaccine administration. In modifying the notification provisions of the rule to apply only when requested by a patient, the proposed rule change would reduce the administrative burden of preparing and forwarding potentially redundant information that is not always needed or desired by every primary care provider, especially considering that pharmacies also report administered vaccines to the California Immunization Registry. Considering pharmacist and pharmacy workload demands having amplified during the COVID-19 pandemic, eliminating unnecessary administrative requirements free up pharmacy personnel to focus on meeting public demand for increased pharmacy services.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.